SCHEMBL31716260

SCHEMBL31716260

O=c1[nH]c(Cc2ccc(-c3cc(F)cc(F)c3)nc2)nc2cc(Br)c(Cl)cc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ LMNA P02545 3/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ TUBB4A P04350 1/20 0.34
▸ TUBB P07437 1/20 0.34
▸ TUBA3C P0DPH7 1/20 0.34
▸ TUBA1B P68363 1/20 0.34
▸ TUBA4A P68366 1/20 0.34
▸ TUBB4B P68371 1/20 0.34
▸ TUBB3 Q13509 1/20 0.34
▸ TUBB2A Q13885 1/20 0.34
▸ TUBB8 Q3ZCM7 1/20 0.34
▸ TUBA3E Q6PEY2 1/20 0.34
▸ TUBA1A Q71U36 1/20 0.34
▸ TUBA1C Q9BQE3 1/20 0.34
▸ TUBB6 Q9BUF5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31716019 0.89 PDE5A (0.38) PDE5AKMT2ALMNAKDM4EMAPT
SCHEMBL31716946 0.85 LMNA (0.44) LMNAKDM4EROCK2PDE10AMET
SCHEMBL31716050 0.85 LMNA (0.43) LMNAKDM4EMAPTROCK2MET
SCHEMBL31716038 0.84 KDM4E (0.37) KMT2ALMNAKDM4ENPC1RAB9A
SCHEMBL31716279 0.81 USP2 (0.39) KDM4ECACNA1BPOLBALDH1A1HPGD
SCHEMBL31716894 0.81 MET (0.37) KMT2ALMNAMAPTNPC1RAB9A
SCHEMBL31715976 0.79 KDM4E (0.49) KMT2ALMNAKDM4ETUBB4ATUBB
SCHEMBL31717042 0.79 LMNA (0.43) LMNAKDM4EMAPTROCK2PDE10A
SCHEMBL31716955 0.79 LMNA (0.43) LMNAKDM4EMAPTROCK2MET
SCHEMBL31716882 0.78 MAPK1 (0.46) LMNAKDM4EROCK2PDE10AMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025227032-A1 METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-10-30 — — WO disclosed
Send feedback